PTC Therapeutics PTCT Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is PTC Therapeutics's investment purchases?
- PTC Therapeutics (PTCT) reported investment purchases of $454.67M in Q1 2026.
- How has PTC Therapeutics's investment purchases changed year-over-year?
- PTC Therapeutics's investment purchases increased by 41.1% year-over-year, from $322.34M to $454.67M.
- What is the long-term trend for PTC Therapeutics's investment purchases?
- Over 4 years (2021 to 2025), PTC Therapeutics's investment purchases has grown at a 42.2% compound annual growth rate (CAGR), from $333.15M to $1.36B.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.